U.S. Specialty Stores Stock News

Expedia Group (EXPE) is back in focus as investors weigh upbeat earnings expectations alongside the company’s new creator partnership with IShowSpeed, a bid to reach Gen Z travelers ahead of the upcoming results. See our latest analysis for Expedia Group. At a share price of US$251.84, Expedia Group has seen an 11.78% 1 month share price return, while its 1 year total shareholder return of 56.93% points to momentum that investors are now reassessing ahead of earnings and the CFO...

In recent months, Burlington Stores reported an 11.3% year-on-year revenue increase that beat analyst expectations and delivered stronger-than-forecast EBITDA, while at the same time issuing next-quarter EPS guidance that fell short of market forecasts. Separately, Vanguard Capital Management disclosed beneficial ownership of 3,362,230 Burlington shares, representing 5.36% of the company’s common stock with sole dispositive power, but without signaling any intention to influence corporate...

AbbVie (ABBV) just posted first quarter 2026 results that topped Wall Street expectations, with management lifting full year revenue and EPS guidance after solid contributions from immunology, neuroscience and migraine treatments. See our latest analysis for AbbVie. Despite strong product news and an earnings beat, AbbVie’s share price return has slipped year to date with a 9.9% decline. The 1 year total shareholder return of 7.5% and 5 year total shareholder return of about 2.2x suggest...

Avantor expanded its Masterflex fluid handling portfolio, focusing on interoperable and scalable bioprocessing solutions for life sciences customers. The company highlighted these Masterflex upgrades at INTERPHEX 2026, using the industry event to showcase operational integration and bioprocessing capabilities. These product moves come alongside leadership changes and early signs of business stabilization in certain segments. For investors watching NYSE:AVTR, the product work around...

In the first quarter ended March 31, 2026, QuantumScape Corporation reported a reduced net loss of US$100.8 million, or US$0.16 per share, compared with a net loss of US$114.42 million, or US$0.21 per share, a year earlier. Separately, QuantumScape’s CEO transferred 212,075 Class A shares as a bona fide gift for estate planning while retaining more than 5.2 million shares, which may reassure investors about leadership’s ongoing alignment with the company’s long-term prospects. We’ll now...

Veeva Systems (VEEV) is set to join the S&P 500 Index on May 7, 2026, after a share price surge that has drawn fresh attention to its life sciences software business and AI driven product push. See our latest analysis for Veeva Systems. The S&P 500 news comes after a mixed period for investors, with a 1 day share price return of 10.02% and a year to date share price return decline of 21.82%, while the 1 year total shareholder return decline of 27.44% points to weaker longer term sentiment...

Willis Towers Watson recently reported past first-quarter 2026 results, with revenue rising to US$2,412 million and net income to US$297 million, alongside higher basic and diluted earnings per share from continuing operations year over year. At the same time, the company deepened its AI focus and leadership bench through the Newfront integration and senior appointments, signalling an effort to align technology, talent and growth plans across North America. We’ll now examine how WTW’s...

Crystal Valley Financial (CYVF) opened 2026 with Q1 results that follow a year where trailing twelve month revenue ranged between about US$33.0 million and US$34.9 million and basic EPS sat between US$8.2 and US$9.3, alongside a net margin of 31.2% over the last 12 months. Over recent quarters the company has seen quarterly revenue run between US$7.0 million and US$9.4 million, while quarterly basic EPS moved in a band from about US$1.16 to US$2.63. This gives investors a clear read on how...

Wondering if Weyerhaeuser is quietly offering value at its current price, or if the recent share performance is a warning sign? This article breaks down what the numbers actually suggest. The stock last closed at US$23.99, with returns of a 4.2% decline over the past week, a 1.8% decline over the past month, a 0.8% gain year to date, and returns of a 5.1% decline, 11.6% decline, and 26.4% decline over the past 1, 3 and 5 years respectively. Recent attention on Weyerhaeuser has focused on how...

In late April 2026, Newmont Corporation reported first-quarter 2026 results showing higher sales of US$7,307 million and net income of US$3,262 million year over year, while also confirming a US$0.26 per-share dividend for shareholders of record on May 27, 2026 and launching a US$6.00 billion share repurchase program with no set end date. Together, the stronger earnings, continued dividend and sizeable buyback highlight Newmont’s focus on returning cash to shareholders while signaling...

Earlier this week, the zoning board of Sharon, Pennsylvania approved Keel Infrastructure’s plan to expand its former industrial-site campus into a 110MW data center using Nvidia’s Vera Rubin hardware, subject to local noise and water-use limits and further permitting before construction can begin. This approval underscores Keel’s shift from bitcoin mining toward supplying power-rich, AI-focused infrastructure, supported by a sizeable 2.2-gigawatt development pipeline across key North...

Recent share performance and business snapshot On Holding (NYSE:ONON) has seen mixed share performance recently, with a return of about 4.6% over the past month but a decline of roughly 24.8% over the past 3 months. The company reports annual revenue of US$3,014.0m and net income of US$203.7m, with revenue growth of 14.9% and net income growth of 24.5%. These figures give investors a snapshot of its current scale and profitability. See our latest analysis for On Holding. The recent 1 day...

Regulatory milestone sets the tone for COMPASS Pathways stock The latest move in COMPASS Pathways (CMPS) stock is closely tied to the FDA granting a rolling New Drug Application review and selecting COMP360 for the Commissioner's National Priority Voucher program in treatment resistant depression. See our latest analysis for COMPASS Pathways. Against the backdrop of this FDA progress, COMPASS Pathways’ 55.6% 1 month share price return and 37.6% year to date share price return contrast with a...

AeroVironment (AVAV) just put its counter drone and directed energy capabilities in the spotlight with the launch of its modular Halo_Shield system and a successful LOCUST laser test at sea, drawing fresh attention to the stock. See our latest analysis for AeroVironment. Despite the recent C UAS and directed energy headlines, AeroVironment’s share price has been under pressure, with a 90 day share price return showing a 31.49% decline even as the 1 year total shareholder return sits at...

In late April 2026, The Vita Coco Company reported first‑quarter net sales of US$179.77 million and net income of US$30.47 million, then raised its full‑year 2026 net sales guidance to US$720 million–US$735 million, reflecting stronger‑than‑expected growth in Vita Coco Coconut Water and improving private label trends. The combination of this earnings beat, higher guidance and margin support from tariff relief has strengthened analyst confidence in Vita Coco’s earnings outlook and reinforced...

Alexandria Real Estate Equities (ARE) is back on investor radar after first quarter 2026 results, with net income of US$361.65 million and earnings of US$2.10 per share replacing last year’s loss. See our latest analysis for Alexandria Real Estate Equities. Despite the stronger first quarter earnings, Alexandria’s share price return tells a different story. A 2.17% 1 day gain to US$41.39 stands against a 23.56% 3 month share price decline and a 40.73% 1 year total shareholder return loss,...

Why a governance proposal is putting Norwegian Cruise Line Holdings (NCLH) in focus Norwegian Cruise Line Holdings (NCLH) just drew investor attention after The Accountability Board, Inc. filed a proposal to shift the company to annually elected directors ahead of its June 11, 2026 shareholder meeting. This governance push comes at a time when traders are already watching NCLH more closely. Recent sector strength, questions around costs and geopolitical risk, and the upcoming earnings release...

Recent analyst calls on Full Truck Alliance (YMM) have drawn fresh attention to the stock, with both Citi and JPMorgan highlighting expectations around order growth, momentum, and the upcoming Q1 2026 earnings release. See our latest analysis for Full Truck Alliance. Despite recent analyst optimism and upcoming Q1 2026 results, Full Truck Alliance’s share price of US$8.61 reflects a 30 day share price return of 4.87%, compared with a year to date share price decline of 23.47% and a 1 year...

Weatherford International (WFRD) is back in focus after first quarter 2026 results showed higher net income on slightly lower revenue, along with reaffirmed revenue guidance, a fresh cash dividend, and a planned corporate move to Texas. See our latest analysis for Weatherford International. The latest earnings, confirmed 2026 revenue guidance, share repurchases and the new dividend seem to be reflected in strong price momentum, with a 30 day share price return of 14.9% and a very large 1 year...

Nektar Therapeutics (NKTR) recently reported 52-week Phase 2b REZOLVE-AA data for rezpegaldesleukin in severe alopecia areata, alongside US$699 million of fresh funding and plans to move the program into Phase 3 trials. See our latest analysis for Nektar Therapeutics. Nektar’s share price has swung sharply over the past year, with a 30 day share price return of 12.30% and a 90 day share price return of 126.81%, while the 1 year total shareholder return is very large, alongside fresh REZOLVE...

Olema Pharmaceuticals (NasdaqGS:OLMA) has appointed Prakash Raman, Ph.D., to its Board of Directors. Dr. Raman is an industry veteran with extensive executive and business development experience at large biopharmaceutical companies. This board change marks a fresh leadership development for Olema that had not been covered in earlier materials. For readers following Olema Pharmaceuticals, this move adds a board member with a long track record in oncology partnerships and acquisitions. The...

AppLovin (APP) heads into a busy stretch, with investors watching the May 6 Q1 earnings release and the planned Axon Ads e-commerce rollout as sentiment tracks recent analyst estimate revisions. See our latest analysis for AppLovin. The current US$460.0 share price follows a 19.06% one-month share price return and a 25.60% decline year to date. The 1 year total shareholder return of 49.55% highlights strong longer term momentum as investors weigh Axon Ads and upcoming earnings against...

CVS Health (CVS) is back in focus after reaffirming its earnings guidance and outlining plans to improve Aetna margins, as investors digest a higher than expected 2027 Medicare Advantage payment update and easing regulatory questions around insulin pricing. See our latest analysis for CVS Health. The reaffirmed earnings outlook and support for Aetna margins have arrived alongside a 30 day share price return of 11.7% and a 1 year total shareholder return of 26.1%. This suggests recent momentum...

Why JinkoSolar is Drawing Fresh Attention Now JinkoSolar Holding (NYSE:JKS) is back on many watchlists after a year in which the stock’s total return sits around 43%, a sharp contrast to its weaker multi year performance profile. That rebound comes alongside annual revenue of US$65,497.65m and a reported net loss of CN¥4,445.09m. This has prompted investors to reassess how the market is currently pricing JinkoSolar’s large scale solar manufacturing footprint and global customer base. See our...